Your browser doesn't support javascript.
loading
Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase.
Mascarenhas, John O; Rampal, Raajit K; Kosiorek, Heidi E; Bhave, Rupali; Hexner, Elizabeth; Wang, Eunice S; Gerds, Aaron; Abboud, Camille N; Kremyanskaya, Marina; Berenzon, Dimitry; Odenike, Olatoyosi; Farnoud, Noushin; Krishnan, Aishwarya; Weinberg, Rona Singer; McGovern, Erin; Salama, Mohamed E; Najfeld, Vesna; Medina-Martinez, Juan S; Arango Ossa, Juan E; Levine, Max F; Zhou, Yangyu; Sandy, Lonette; Heaney, Mark L; Levine, Ross L; Mesa, Ruben A; Dueck, Amylou C; Hoffman, Ronald.
Affiliation
  • Mascarenhas JO; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Rampal RK; Leukemia Service, Department of Medicine.
  • Kosiorek HE; Center for Hematologic Malignancies, and.
  • Bhave R; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hexner E; Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ.
  • Wang ES; Wake Forest Baptist Health, Winston-Salem, NC.
  • Gerds A; University of Pennsylvania, Philadelphia, PA.
  • Abboud CN; Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Kremyanskaya M; Leukemia and Myeloid Disorders Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
  • Berenzon D; Washington University in St. Louis School of Medicine, St. Louis, MO.
  • Odenike O; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Farnoud N; Wake Forest Baptist Health, Winston-Salem, NC.
  • Krishnan A; The University of Chicago Medicine and Comprehensive Cancer Center, Chicago, IL.
  • Weinberg RS; Center for Hematologic Malignancies, and.
  • McGovern E; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Salama ME; Center for Hematologic Malignancies, and.
  • Najfeld V; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Medina-Martinez JS; New York Blood Center, New York, NY.
  • Arango Ossa JE; Center for Hematologic Malignancies, and.
  • Levine MF; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Zhou Y; Department of Pathology, Mayo Clinic, Rochester, MN.
  • Sandy L; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Heaney ML; Department of Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Levine RL; Department of Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Mesa RA; Department of Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Dueck AC; Department of Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hoffman R; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Blood Adv ; 4(20): 5246-5256, 2020 10 27.
Article in En | MEDLINE | ID: mdl-33104796
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrazoles / Blast Crisis Type of study: Clinical_trials Limits: Humans Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrazoles / Blast Crisis Type of study: Clinical_trials Limits: Humans Language: En Year: 2020 Type: Article